Stille

Stille Financial Leverage

The Financial Leverage (Equity Multiplier) of Stille (STIL.ST) as of Oct 24, 2026 is 1.49. In the previous year, Financial Leverage (Equity Multiplier) was 1.43 — a change of 3.93% (higher).

Financial Leverage

1.49

YoY

3.93%

Last updated:

Financial Leverage (Equity Multiplier) of Stille is 2025 1.49 . Financial Leverage (Equity Multiplier) of Stille was 2024 1.43 . It decreases by 3.93% higher compared to the previous year.

The Stille Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.34 SEK
Jan 1, 2019
1.58 SEK
Jan 1, 2020
1.48 SEK
Jan 1, 2021
2.09 SEK
Jan 1, 2022
1.80 SEK
Jan 1, 2023
1.27 SEK
Jan 1, 2024
1.43 SEK
Jan 1, 2025
1.49 SEK
The Stille Financial Leverage history
YEARFinancial LeverageYoY
1.49+3.93%
1.43+12.44%
1.27-29.46%
1.80-13.46%
2.09+40.43%
1.48-5.83%
1.58+17.75%
1.34+3.27%
1.30+0.50%
1.29-9.06%
1.42-2.03%
1.45—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stille Stock analysis

What does Stille do? Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings. Stille is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stille stock

Financial Leverage (Equity Multiplier) of Stille is 1.49 in 2025.

Financial Leverage (Equity Multiplier) of Stille changed from 1.43 to 1.49, representing a 3.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Stille since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Stille with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Stille

All Key Metrics — Stille